| Literature DB >> 29295581 |
Felipe Vidal1, Pilar Vásquez2, Francisca R Cayumán3, Carola Díaz4, Jorge Fuentealba5, Luis G Aguayo6, Gonzalo E Yévenes7, Joel Alderete8, Leonardo Guzmán9.
Abstract
One of the most studied nanocarriers for drug delivery are polyamidoamine (PAMAM) dendrimers. However, the alterations produced by PAMAM dendrimers in neuronal function have not been thoroughly investigated, and important aspects such as effects on synaptic transmission remain unexplored. We focused on the neuronal activity disruption induced by dendrimers and the possibility to prevent these effects by surface chemical modifications. Therefore, we studied the effects of fourth generation PAMAM with unmodified positively charged surface (G4) in hippocampal neurons, and compared the results with dendrimers functionalized in 25% of their surface groups with folate (PFO25) and polyethylene glycol (PPEG25). G4 dendrimers significantly reduced cell viability at 1 µM, which was attenuated by both chemical modifications, PPEG25 being the less cytotoxic. Patch clamp recordings demonstrated that G4 induced a 7.5-fold increment in capacitive currents as a measure of membrane permeability. Moreover, treatment with this dendrimer increased intracellular Ca2+ by 8-fold with a complete disruption of transients pattern, having as consequence that G4 treatment increased the synaptic vesicle release and frequency of synaptic events by 2.4- and 3-fold, respectively. PFO25 and PPEG25 treatments did not alter membrane permeability, total Ca2+ intake, synaptic vesicle release or synaptic activity frequency. These results demonstrate that cationic G4 dendrimers have neurotoxic effects and induce alterations in normal synaptic activity, which are generated by the augmentation of membrane permeability and a subsequent intracellular Ca2+ increase. Interestingly, these toxic effects and synaptic alterations are prevented by the modification of 25% of PAMAM surface with either folate or polyethylene glycol.Entities:
Keywords: PAMAM dendrimers; drug delivery; nanocarriers; nanosafety; neurotoxicity of nanomaterials; safe nanomaterial design; synaptic effects
Year: 2017 PMID: 29295581 PMCID: PMC5791094 DOI: 10.3390/nano8010007
Source DB: PubMed Journal: Nanomaterials (Basel) ISSN: 2079-4991 Impact factor: 5.076
Figure 1Schematic representation of studied dendrimers. (a) G4: Fourth generation PAMAM dendrimer with a completely positively charged surface (red); (b) PFO25: G4 functionalized in 25% of the surface with folate (purple); (c) PPEG25: G4 functionalized in 25% of the surface with polyethylene glycol (gray).
Figure 2Cytotoxicity evaluation. Cell viability assay was performed incubating hippocampal neurons for 24 h with G4, PFO25 and PPEG25. Incubation only with culture media and Triton were used as positive and negative viability controls, respectively. Fluorescent emission of AlamarBlue reagent was measured and results are expressed as percentage of cell viability considering the fluorescence of positive control as 100% of viability. Significant differences between dendrimer treatments and positive control were analyzed (n = 6; ** p < 0.01).
Figure 3Membrane permeability effects. (a) Representative traces of capacitive currents under G4, PFO25 and PPEG25 treatments at 30 min of recording. Solution without dendrimers was used as control; (b) membrane charge transferred for different treatments for 30 min period of recording (n = 7, ** p < 0.01).
Figure 4Analysis of intracellular Ca2+ transients. (a) Representative traces of intracellular Ca2+ transients patterns under G4, PFO25 and PPEG25 treatments. Solution without dendrimers was used as control; (b) quantification of the area under the curve for Ca2+ transients for different treatments; (c) quantification of frequency of Ca2+ transients for different treatments (n = 15, * p < 0.05, ** p < 0.01).
Figure 5Synaptic vesicle release study. (a) Fluorescence intensity decay of FM 1-43 dye under G4, PFO25 and PPEG25 treatments. Solution without dendrimers was used as control. Black line in curves shows the nonlinear fit regression for each condition; (b) decay rate constants K of nonlinear fit regression for different treatments.
Figure 6Effects of dendrimer treatments on synaptic activity. (a) Representative traces of synaptic activity recordings under G4, PFO25 and PPEG25 treatments. Solution without dendrimers was used as control; (b) quantification of synaptic activity frequency for different treatments (n = 9, ** p < 0.01); (c) cumulative probability of amplitude values for different treatments. No significant differences were found.